Eureka Therapeutics, Inc
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
Seedtable Score
28
Startups
2
Funding Rounds
$105.0m
Money raised
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Eureka Therapeutics, Inc has raised a total of $45m in funding over 2 rounds.
Key Insights:
- Eureka Therapeutics Series E round, March 2020: $45m
- Eureka Therapeutics Inc funding round, January 2018: $60m
Eureka Therapeutics Series E round, March 2020
$45m
Eureka Therapeutics Inc funding round, January 2018
$60m
Industries
Eureka Therapeutics, Inc is active in the following industries: